• Product NameRitonavir
• Brief DescriptionInhibitors
• Purification99.50%
• Biological ActivityRitonavir is an antiretroviral (HIV) drug which inhibits a particular liver enzyme that normally metabolizes protease inhibitors, cytochrome P450-3A4 (CYP3A4).
• Target NameHIV Protease inhibitor
• CAS No. 155213-67-5
• Calculated MW 720.96
• Formulation C37H48N6O5S2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
  Pathways:Microbiology&virology; Proteases/Proteasome
  Receptor:HIV Protease
  Boling pt:947C
  Melting pt:120-122C
  Solubility:Ethanol: 3 mg/mL (4.16 mM); DMSO: 100 mg/mL (138.7 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Garriga C, et al. J Med Virol. 2007 Nov; 79(11):1617-28.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting